SOD1P2

Across TCGA pan-cancer cohorts, SOD1P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated SOD1P2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher SOD1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SOD1P2 expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

UCS, UCEC, and CESC are the cancer types where SOD1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	III,IV	0.086	0.443	.007	72	view →
UCEC	DFS	Tertile	All	0.655	0.850	<.001	72	view →
CESC	OS	Tertile	III,IV	0.068	0.756	<.001	36	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	21	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	18	view →
GBM	OS	Tertile	All	0.232	0.441	.001	18	view →
LIHC	OS	Tertile	III,IV	0.603	0.256	.011	9	view →
KICH	DFS	Tertile	All	0.425	0.847	.041	3	view →
HNSC	DFS	Tertile	All	0.397	0.669	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

SOD1P2–UCS (DFS)

Open the UCS breakdown →